Chronic inflammatory diseases, such as rheumatoid arthritis, steatohepatitis, periodontitis,
chronic kidney disease, and others are associated with an increased risk of atherosclerotic …

Purpose Chronic hemodialysis patients experience accelerated atherosclerosis contributed
to by dyslipidemia, inflammation, and an impaired antioxidant system. Vitamin E tocotrienols …

High‐density lipoprotein (HDL) is a lipid and protein complex that consists of
apolipoproteins and lower level HDL‐associated enzymes. HDL dysfunction is a factor in …

Patients with chronic kidney disease (CKD) exhibit a myriad of metabolic derangements,
including dyslipidemia characterized by low plasma concentrations of high-density …

Chronic renal failure (CRF) is associated with the development of cardiovascular disease
(CVD). Paraoxonase 1 (PON1), an antioxidant enzyme, shows cardioprotective properties …

Abstract Background Paraoxonase 1 (PON1) activity is lower in renal failure patients. We
hypothesize that part of the salutatory effect of hemodialysis on PON1 activity that we have …

Objective—A novel phospholipase assay was used to measure for the first time the behavior
of endothelial and hepatic phospholipase activities in postheparin human plasma of …

Abstract Background and Objectives: Apolipoprotein E (apoE) plays a central role in the
metabolism and homeostasis of lipids. ApoE gene encodes three major isoforms: ε2, ε3 and …

La disminución de colesterol-LDL (c-LDL) se considera meta principal del tratamiento de
pacientes con riesgo cardiovascular. Sin embargo, pacientes con Enfermedad Renal …

Abstract Background: Type 2 diabetes (T2DM) and chronic renal disease constitute
important risk factors of atherosclerotic cardiovascular disease, associated with lipid …